Top

Critical Care

Published in:

Open Access 01-12-2005 | Research

Elevated troponin and myocardial infarction in the intensive care unit: a prospective study

Authors: Wendy Lim, Ismael Qushmaq, Deborah J Cook, Mark A Crowther, Diane Heels-Ansdell, PJ Devereaux

Published in: Critical Care | Issue 6/2005

Abstract

Introduction

Elevated troponin levels indicate myocardial injury but may occur in critically ill patients without evidence of myocardial ischemia. An elevated troponin alone cannot establish a diagnosis of myocardial infarction (MI), yet the optimal methods for diagnosing MI in the intensive care unit (ICU) are not established. The study objective was to estimate the frequency of MI using troponin T measurements, 12-lead electrocardiograms (ECGs) and echocardiography, and to examine the association of elevated troponin and MI with ICU and hospital mortality and length of stay.

Method

In this 2-month single centre prospective cohort study, all consecutive patients admitted to our medical-surgical ICU were classified in duplicate by two investigators as having MI or no MI based on troponin, ECGs and echocardiograms obtained during the ICU stay. The diagnosis of MI was based on an adaptation of the joint European Society of Cardiology/American College of Cardiology definition: a typical rise or fall of an elevated troponin measurement, in addition to ischemic symptoms, ischemic ECG changes, a coronary artery intervention, or a new cardiac wall motion abnormality.

Results

We screened 117 ICU admissions and enrolled 115 predominantly medical patients. Of these, 93 (80.9%) had at least one ECG and one troponin; 44 of these 93 (47.3%) had at least one elevated troponin and 24 (25.8%) had an MI. Patients with MI had significantly higher mortality in the ICU (37.5% versus 17.6%; P = 0.050) and hospital (50.0% versus 22.0%; P = 0.010) than those without MI. After adjusting for Acute Physiology and Chronic Health Evaluation II score and need for inotropes or vasopressors, MI was an independent predictor of hospital mortality (odds ratio 3.22, 95% confidence interval 1.04–9.96). The presence of an elevated troponin (among those patients in whom troponin was measured) was not independently predictive of ICU or hospital mortality.

Conclusion

In this study, 47% of critically ill patients had an elevated troponin but only 26% of these met criteria for MI. An elevated troponin without ischemic ECG changes was not associated with adverse outcomes; however, MI in the ICU setting was an independent predictor of hospital mortality.

Available only for authorised users

Katus HA, Remppis A, Looser S, Hallermeier K, Scheffold T, Kubler W: Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 1989, 21: 1349-1353. 10.1016/0022-2828(89)90680-9CrossRefPubMed

Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined – a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36: 959-969. 10.1016/S0735-1097(00)00804-4CrossRefPubMed

Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, Minder EI, Rickli H, Fehr T: Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003, 41: 2004-2009. 10.1016/S0735-1097(03)00421-2CrossRefPubMed

Ammann P, Fehr T, Minder EI, Gunter C, Bertel O: Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001, 27: 965-969. 10.1007/s001340100920CrossRefPubMed

Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, Goldberg RJ, Hand MM, Jaffe AS, Julian DG, et al.: Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003, 108: 2543-2549. 10.1161/01.CIR.0000100560.46946.EACrossRefPubMed

Booker KJ, Holm K, Drew BJ, Lanuza DM, Hicks FD, Carrigan T, Wright M, Moran J: Frequency and outcomes of transient myocardial ischemia in critically ill adults admitted for noncardiac conditions. Am J Crit Care 2003, 12: 508-517.PubMed

Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E: Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996, 335: 1342-1349. 10.1056/NEJM199610313351802CrossRefPubMed

Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M: Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BMJ 1996, 313: 262-264.PubMedCentralCrossRefPubMed

Lindahl B, Venge P, Wallentin L: Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 1996, 93: 1651-1657.CrossRefPubMed

10.

Galvani M, Ottani F, Ferrini D, Ladenson JH, Destro A, Baccos D, Rusticali F, Jaffe AS: Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997, 95: 2053-2059.CrossRefPubMed

11.

Newby LK, Christenson RH, Ohman EM, Armstrong PW, Thompson TD, Lee KL, Hamm CW, Katus HA, Cianciolo C, Granger CB, et al.: Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation 1998, 98: 1853-1859.CrossRefPubMed

12.

Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L, Goldmann B, Katus HA: The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992, 327: 146-150.CrossRefPubMed

13.

Relos RP, Hasinoff IK, Beilman GJ: Moderately elevated serum troponin concentrations are associated with increased morbidity and mortality rates in surgical intensive care unit patients. Crit Care Med 2003, 31: 2598-2603. 10.1097/01.CCM.0000089931.09635.D2CrossRefPubMed

14.

Baillard C, Boussarsar M, Fosse JP, Girou E, Le Toumelin P, Cracco C, Jaber S, Cohen Y, Brochard L: Cardiac troponin I in patients with severe excerbation of chronic obstructive pulmonary disease. Intensive Care Med 2003, 29: 584-589.PubMed

15.

ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK: Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000, 46: 650-657.PubMed

16.

Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr: National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999, 45: 1104-1121.PubMed

17.

Guest TM, Ramanathan AV, Tuteur PG, Schechtman KB, Ladenson JH, Jaffe AS: Myocardial injury in critically ill patients. A frequently unrecognised complication. JAMA 1995, 273: 1945-1949. 10.1001/jama.273.24.1945CrossRefPubMed

18.

Kollef MH, Ladenson JH, Eisenberg PR: Clinically recognized cardiac dysfunction: an independent determinant of mortality among critically ill patients. Is there a role for serial measurement of cardiac troponin I? Chest 1997, 111: 1340-1347.CrossRefPubMed

19.

Noble JS, Reid AM, Jordan LV, Glen AC, Davidson JA: Troponin I and myocardial injury in the ICU. Br J Anaesth 1999, 82: 41-46.CrossRefPubMed

20.

Scirica BM, Morrow DA: Troponins in acute coronary syndromes. Prog Cardiovasc Dis 2004, 47: 177-188. 10.1016/j.pcad.2004.07.004CrossRefPubMed

21.

Klein Gunnewiek JM, van de Leur JJ: Elevated troponin T concentrations in critically ill patients. Intensive Care Med 2003, 29: 2317-2322. 10.1007/s00134-003-1953-2CrossRefPubMed

22.

Spies C, Haude V, Fitzner R, Schroder K, Overbeck M, Runkel N, Schaffertzik W: Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 1998, 113: 1055-1063.CrossRefPubMed

23.

La Vecchia L, Ottani F, Favero L, Spadaro GL, Rubboli A, Boanno C, Mezzena G, Fontanelli A, Jaffe AS: Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism. Heart 2004, 90: 633-637. 10.1136/hrt.2003.019745PubMedCentralCrossRefPubMed

24.

Lehrke S, Steen H, Sievers HH, Peters H, Opitz A, Muller-Bardorff M, Wiegand UK, Katus HA, Giannitsis E: Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery. Clin Chem 2004, 50: 1560-1567. 10.1373/clinchem.2004.031468CrossRefPubMed

25.

Lyon WJ, Baker RA, Andrew MJ, Tirimacco R, White GH, Knight JL: Relationship between elevated preoperative troponin T and adverse outcomes following cardiac surgery. ANZ J Surg 2003, 73: 40-44. 10.1046/j.1445-2197.2003.02611.xCrossRefPubMed

26.

Baggish AL, MacGillivray TE, Hoffman W, Newell JB, Lewandrowski KB, Lee-Lewandrowski E, Anwaruddin S, Siebert U, Januzzi JL: Postoperative troponin-T predicts prolonged intensive care unit length of stay following cardiac surgery. Crit Care Med 2004, 32: 1866-1871. 10.1097/01.CCM.0000139692.19371.7CCrossRefPubMed

27.

ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988, 2: 349-360.

28.

Antiplatelet Trialists' Collaboration: Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 2002, 324: 71-86. 10.1136/bmj.324.7336.S71CrossRef

29.

Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators: Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001, 358: 605-613. 10.1016/S0140-6736(01)05775-0CrossRef

30.

Lindahl B, Diderholm E, Lagerquist B, Venge P, Wallentin L: Effects on mortality of long-term treatent with low molecular weight heparin in relation to troponin T level and ECG findings – a FRISC 2 substudy. Eur Heart J 2000, 521.

31.

Martinez EA, Kim LJ, Faraday N, Rosenfeld B, Bass EB, Perler BA, Williams GM, Dorman T, Pronovost PJ: Sensitivity of routine intensive care unit surveillance for detecting myocardial ischemia. Crit Care Med 2003, 31: 2302-2308. 10.1097/01.CCM.0000084857.87446.DDCrossRefPubMed

32.

Chow T-C: Electrocardiography in Clinical Practice: Adult and Pediatric. 4th edition. Philadelphia: WB Saunders Company; 1996.

Title: Elevated troponin and myocardial infarction in the intensive care unit: a prospective study
Authors: Wendy Lim
Ismael Qushmaq
Deborah J Cook
Mark A Crowther
Diane Heels-Ansdell
PJ Devereaux
Publication date: 01-12-2005
Publisher: BioMed Central
Published in: Critical Care / Issue 6/2005
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc3816

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Elevated troponin and myocardial infarction in the intensive care unit: a prospective study

Abstract

Introduction

Method

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2005

Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630]

Bench-to-bedside review: Paediatric viral lower respiratory tract disease necessitating mechanical ventilation – should we use exogenous surfactant?

The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study

Open the intensive care unit doors to HIV-infected patients with sepsis

Quantifying bedside-derived imaging of microcirculatory abnormalities in septic patients: a prospective validation study

Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial [ISRCTN38797445]